JP2015519322A5 - - Google Patents

Download PDF

Info

Publication number
JP2015519322A5
JP2015519322A5 JP2015509395A JP2015509395A JP2015519322A5 JP 2015519322 A5 JP2015519322 A5 JP 2015519322A5 JP 2015509395 A JP2015509395 A JP 2015509395A JP 2015509395 A JP2015509395 A JP 2015509395A JP 2015519322 A5 JP2015519322 A5 JP 2015519322A5
Authority
JP
Japan
Prior art keywords
alkyl
group
groups
cycloalkyl
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2015509395A
Other languages
English (en)
Japanese (ja)
Other versions
JP6236702B2 (ja
JP2015519322A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2013/058840 external-priority patent/WO2013164292A1/en
Publication of JP2015519322A publication Critical patent/JP2015519322A/ja
Publication of JP2015519322A5 publication Critical patent/JP2015519322A5/ja
Application granted granted Critical
Publication of JP6236702B2 publication Critical patent/JP6236702B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2015509395A 2012-04-30 2013-04-29 インダニルオキシジヒドロベンゾフラニル酢酸 Active JP6236702B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12166095 2012-04-30
EP12166095.5 2012-04-30
PCT/EP2013/058840 WO2013164292A1 (en) 2012-04-30 2013-04-29 Indanyloxydihydrobenzofuranylacetic acids

Publications (3)

Publication Number Publication Date
JP2015519322A JP2015519322A (ja) 2015-07-09
JP2015519322A5 true JP2015519322A5 (enExample) 2016-06-23
JP6236702B2 JP6236702B2 (ja) 2017-11-29

Family

ID=48325664

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015509395A Active JP6236702B2 (ja) 2012-04-30 2013-04-29 インダニルオキシジヒドロベンゾフラニル酢酸

Country Status (7)

Country Link
US (1) US8809376B2 (enExample)
EP (1) EP2844653B1 (enExample)
JP (1) JP6236702B2 (enExample)
AR (1) AR090879A1 (enExample)
TW (1) TW201406739A (enExample)
UY (1) UY34773A (enExample)
WO (1) WO2013164292A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2953681B1 (en) * 2013-02-06 2017-03-15 Boehringer Ingelheim International GmbH New indanyloxydihydrobenzofuranylacetic acids
AU2014372114A1 (en) 2013-11-14 2016-06-09 Cadila Healthcare Limited Novel heterocyclic compounds
WO2019160882A1 (en) 2018-02-13 2019-08-22 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
WO2019204609A1 (en) 2018-04-19 2019-10-24 Gilead Sciences, Inc. Pd-1/pd-l1 inhibitors
BR112020026746A2 (pt) 2018-07-13 2021-03-30 Gilead Sciences, Inc. Composto, composição farmacêutica, métodos para inibir pd-1, pd-l1 e/ou a interação de pd-1/pd-l1 e para tratar câncer, e, kit para tratar ou prevenir câncer ou uma doença ou condição.
CN112955435B (zh) 2018-10-24 2024-09-06 吉利德科学公司 Pd-1/pd-l1抑制剂
CN110372651A (zh) * 2019-07-22 2019-10-25 上海师范大学 一种含苯并呋喃骨架的茚衍生物的合成方法
JP2022552655A (ja) 2019-10-07 2022-12-19 キャリーオペ,インク. Gpr119アゴニスト
PH12022552277A1 (en) 2020-02-28 2024-03-04 Kallyope Inc Gpr40 agonists
JP2023526625A (ja) 2020-05-19 2023-06-22 キャリーオペ,インク. Ampkアクチベーター
CN116390925A (zh) 2020-06-26 2023-07-04 卡尔优普公司 Ampk活化剂

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4594611B2 (ja) * 2002-11-08 2010-12-08 武田薬品工業株式会社 受容体機能調節剤
AU2003277576A1 (en) 2002-11-08 2004-06-07 Takeda Pharmaceutical Company Limited Receptor function controlling agent
US7135575B2 (en) * 2003-03-03 2006-11-14 Array Biopharma, Inc. P38 inhibitors and methods of use thereof
EP1630152A4 (en) 2003-05-30 2009-09-23 Takeda Pharmaceutical CONDENSED CYCLIC COMPOUND
JP4805552B2 (ja) * 2003-05-30 2011-11-02 武田薬品工業株式会社 縮合環化合物
WO2007033002A1 (en) 2005-09-14 2007-03-22 Amgen Inc. Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
JPWO2007114213A1 (ja) 2006-03-30 2009-08-13 旭化成ファーマ株式会社 置換二環式環状誘導体及びその用途
ES2379661T3 (es) 2006-06-27 2012-04-30 Takeda Pharmaceutical Company Limited Compuestos cíclicos condensados
MX2010014571A (es) 2008-06-25 2011-03-25 Daiichi Sankyo Co Ltd Compuestos de acido carboxilico.
JP5551707B2 (ja) 2008-10-15 2014-07-16 アムジエン・インコーポレーテツド スピロ環gpr40調節因子
US20120172351A1 (en) 2009-06-09 2012-07-05 Nobuyuki Negoro Novel fused cyclic compound and use thereof
TW201643169A (zh) 2010-07-09 2016-12-16 艾伯維股份有限公司 作為s1p調節劑的螺-哌啶衍生物
HUE025363T2 (en) 2010-12-01 2016-02-29 Boehringer Ingelheim Int Indanyl Oxide Hydrobenzofuranylacetic Acids that can be used to treat metabolic syndrome

Similar Documents

Publication Publication Date Title
JP2015519322A5 (enExample)
JP2009530398A5 (enExample)
JP2010077141A5 (enExample)
JP2013500314A5 (enExample)
JP2009535307A5 (enExample)
JP2013501008A (ja) 抗ウイルス性化合物ならびにそれを含む医薬組成物
JP2010524932A5 (enExample)
JP2013519632A5 (enExample)
JP2011527334A5 (enExample)
JP2010514832A5 (enExample)
JP2009533410A5 (enExample)
JP2015523339A5 (enExample)
JP2020507589A5 (enExample)
JP2010522710A5 (enExample)
RU2012150108A (ru) Аналоги глюкагоноподобного пептида-1 и их применение
CN103102348B (zh) 噁二唑类化合物及其制备方法、药物组合物及其用途
JP2019520344A5 (enExample)
JP2009528997A5 (enExample)
JP2011526286A5 (enExample)
JP2005526773A5 (enExample)
JP2014517848A5 (enExample)
JP2010514734A5 (enExample)
HRP20150064T1 (hr) Kombinacija inzulina i derivata triazina te uporaba iste u lijeäśenju dijabetesa
JP2008530242A5 (enExample)
JP2015524835A5 (enExample)